Section 3204(span) of the SUPPORT for Patients and Communities Act, referred to in subsec. (span)(2), is section 3204(span) of Puspan. L. 115–271, title III, Oct. 24, 2018, 132 Stat. 3946, which is not classified to the Code.

2022—Subsec. (a)(2). Puspan. L. 117–328, § 1262(span)(2), which directed substitution of “the controlled substance is a narcotic drug in schedule III, IV, or V to be administered for the purpose of maintenance or detoxification treatment and is to be administered by injection or implantation;” for “the controlled substance is to be administered for the purpose of maintenance or detoxification treatment under section 823(g)(2) and—”

“(A) the practitioner who issued the prescription is a qualifying practitioner authorized under, and acting within the scope of that section; and

“(B) the controlled substance is to be administered by injection or implantation;”

was executed by making the substitution for “the controlled substance is to be administered for the purpose of maintenance or detoxification treatment under section 823(h)(2) and—” and subpars. (A) and (B), to reflect the probable intent of Congress and the intervening amendment by Puspan. L. 117–215. See Amendment note below.

Puspan. L. 117–215 substituted “823(h)(2)” for “823(g)(2)” in introductory provisions.

Subsec. (a)(5). Puspan. L. 117–328, § 1264, substituted “45 days” for “14 days”.